These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 334012

  • 1. [Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
    Laurens A, Thevenot J, Charron D, Jorry F, Dumonchel P, Martola R.
    Ann Med Interne (Paris); 1977 May; 128(5):493-6. PubMed ID: 334012
    [No Abstract] [Full Text] [Related]

  • 2. [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
    Misset JL, Pouillart P, Amiel JL, Schwarzenberg L, Hayat M, de Vassal F, Musset M, Belpomme D, Jasmin C, Albahary C, Depierre R, Mathé G.
    Nouv Presse Med; 1975 Dec 20; 4(44):3117-20. PubMed ID: 768904
    [Abstract] [Full Text] [Related]

  • 3. [4-year-observation of results of VM 26 treatment of pathologic syndromes from the lymphoma malignum group].
    Lawkowicz W, Polubiec A, Domańska B.
    Acta Haematol Pol; 1975 Dec 20; 6(2):143-7. PubMed ID: 1098351
    [Abstract] [Full Text] [Related]

  • 4. Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
    Rodriguez LH, Johnson DE, Holoye PY, Samuels ML.
    Cancer Treat Rep; 1977 Dec 20; 61(1):87-8. PubMed ID: 324624
    [No Abstract] [Full Text] [Related]

  • 5. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT, Canellos GP, Schein PJ, Chabner BA, Bagley CM, Young RC.
    Proc Natl Cancer Conf; 1972 Dec 20; 7():379-90. PubMed ID: 4587651
    [No Abstract] [Full Text] [Related]

  • 6. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S, Esposito R, Ponti GB, Giangrande A.
    Cancro; 1968 Dec 20; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract] [Full Text] [Related]

  • 7. Synchronization recruitment chemotherapy in non-Hodgkin hematosarcomas.
    Schneider M, Mancini G, Fella C, Aubanel JM, Hoch M, Viguier E.
    Eur J Cancer (1965); 1977 Dec 20; 13(4-5):429-31. PubMed ID: 326556
    [No Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T, Bender RA, Fisher RI, DeVita VT, Chabner BA, Berard CW, Norton L, Young RC.
    Cancer Treat Rep; 1977 Sep 20; 61(6):1057-66. PubMed ID: 71205
    [No Abstract] [Full Text] [Related]

  • 9. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
    Hansen MM, Bloomfield CD, Jørgensen J, Ersbøll J, Pedersen-Bjergaard J, Blom J, Nissen NI.
    Cancer Treat Rep; 1980 Sep 20; 64(10-11):1135-7. PubMed ID: 7459900
    [Abstract] [Full Text] [Related]

  • 10. Non-Hodgkin's lymphomas-present status of chemotherapy.
    Young CW.
    Clin Bull; 1975 Sep 20; 5(1):20-3. PubMed ID: 776444
    [No Abstract] [Full Text] [Related]

  • 11. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y, Gorin NC, Stachowiak J, Najman A, Duhamel G.
    Sem Hop; 1975 Sep 20; 57(41-42):1685-90. PubMed ID: 6272402
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].
    Mathé G, Schwarzenberg L, Pouillart P, Weiner R, Oldham R, Jasmin C, Rosenfeld, Hayat M, Schneider M, Amiel JL, Céoara B, Steresco-Musset M, de Vassal F.
    Nouv Presse Med; 1974 Feb 23; 3(8):447-51. PubMed ID: 4595690
    [No Abstract] [Full Text] [Related]

  • 13. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO.
    Hamatol Bluttransfus; 1976 Feb 23; 18():135-45. PubMed ID: 786808
    [No Abstract] [Full Text] [Related]

  • 14. VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).
    Chiuten DF, Bennett JM, Creech RH, Glick J, Falkson G, Brodovsky HS, Begg CB, Muggia FM, Carbone PP.
    Cancer Treat Rep; 1979 Jan 23; 63(1):7-11. PubMed ID: 369693
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy of malignant lymphoma with adriamycin.
    Gottlieb JA, Gutterman JU, McCredie KB, Rodriguez V, Frei E.
    Cancer Res; 1973 Nov 23; 33(11):3024-8. PubMed ID: 4748450
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW, Kim DY, Yun T, Kim DW, Kim TY, Yoon SS, Heo DS, Bang YJ, Park S, Kim BK, Kim NK.
    Cancer; 2003 Dec 15; 98(12):2651-6. PubMed ID: 14669285
    [Abstract] [Full Text] [Related]

  • 20. Primary lymphoblastic lymphoma of the breast.
    Carbone A, Volpe R, Tirelli U, Veronesi A, Galligioni E, Trovo MG, Grigoletto E.
    Clin Oncol; 1982 Dec 15; 8(4):367-73. PubMed ID: 6897770
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.